demonstrating its value in cancer diagnosis and treatment. Between 2008 and 2023, its oncology immunophenotyping lab saw the number of requests for flow cytometry increase from 3,000 to 8,500 per ...

North America Cancer Therapy Market Size Set Expands at Significant CAGR of 8.15% During 2024-2030 to Reach USD 5.87 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See ...

Learn how environmental pollutants contribute to chronic illness and discover how the principles of environmental medicine ...

A promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of ...

Katie Thurston reveals her HER2-negative breast cancer is treated with hormone therapy instead of chemo, detailing her custom treatment plan.

The rate of appropriate treatment suggestions was 86.6% for Claude3-Opus, 85.7% for GPT4-Turbo, and 75.0% for LLaMa3-70B. Artificial intelligence (AI) can accurately suggest appropriate adjuvant ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

No significant differences in treatment or outcomes were found between most Medicare Advantage (MA) and fee-for-service (FFS) beneficiaries with breast cancer, but Black patients with FFS Medicare ...

Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.

Capivasertib is used to treat incurable breast cancer and has shown to have slowed the disease down. The twice-a-day pill, which is for the most common type of advanced breast can ...